AAAAAA

   
Results: 1-23 |
Results: 23
QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MAHE B MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F BUZYN A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A STAMATOULAS A TILLY H BRICE P MALOISEL F LIOURE B DESABLENS B PIGNON B ABGRALL JP LEPORRIER M DUPRIEZ B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE
Authors: GUILHOT F MALOISEL F GUERCI A MICHALLET M HAROUSSEAU JL BRIERE J ROCHANT H CIURANA AJ ABGRALL JF GUYOTAT D CHRISTIAN B ORFEUVRE H
Citation: F. Guilhot et al., UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE, British Journal of Haematology, 102(1), 1998, pp. 282-283
QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F VEIL A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A TILLY H BRICE B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(1), 1998, pp. 282-282
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E LELEU X SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGUEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 102(1), 1998, pp. 320-321
MYELODYSPLASTIC SYNDROMES - UNUSUAL AND MILD FORMS
Authors: ROCHANT H
Citation: H. Rochant, MYELODYSPLASTIC SYNDROMES - UNUSUAL AND MILD FORMS, Pathologie et biologie, 45(7), 1997, pp. 579-586
INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N IFRAH N ABGRALL JP GUYOTAT D DUPRIEZ B PENY AM BRICE P PIGNON B LEPORRIER M LEPELLEY P FENAUX P
Citation: E. Wattel et al., INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 34-34
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 320-320
THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS
Authors: GUILHOT F GUERCI A FIERE D HAROUSSEAU JL MALOISEL F BOUABDALLAH R GUYOTAT D ROCHANT H NAJMAN A NICOLINI F COLOMBAT P ABGRALL JF IFRAH N BRIERE J BAUTERS F NAVARRO M MORICE P BORDESSOULE D VILQUE JP DESABLENS B TERTIAN G BLANC M CHASTANG C TANZER J
Citation: F. Guilhot et al., THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS, Bone marrow transplantation, 17, 1996, pp. 29-31
MAKING CHOICES IN-HOSPITAL RESOURCES ALLOCATION - THE USE OF AN ASSESSMENT-TOOL TO DECIDE WHICH NEW PROJECTS ARE FINANCED
Authors: DURANDZALESKI I LECLERQ R BAGOT M LEMAIRE F REVUZ J SPETEBROODT Y ZAFRANI ES ROCHANT H
Citation: I. Durandzaleski et al., MAKING CHOICES IN-HOSPITAL RESOURCES ALLOCATION - THE USE OF AN ASSESSMENT-TOOL TO DECIDE WHICH NEW PROJECTS ARE FINANCED, International journal of technology assessment in health care, 12(1), 1996, pp. 163-171
PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS
Authors: SOCIE G MARY JY DEGRAMONT A RIO B LEPORRIER M ROSE C HEUDIER P ROCHANT H CAHN JY GLUCKMAN E
Citation: G. Socie et al., PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS, Lancet, 348(9027), 1996, pp. 573-577
RESULTS OF HEME ARGINATE TREATMENT OF MYELODYSPLASTIC SYNDROMES - A MULTICENTER PHASE-II STUDY OF THE FRENCH GROUP OF MYELODYSPLASTIC SYNDROMES
Authors: ROCHANT H FENAUX P GUERCI A COIFFIER B DREYFUS F BELANGER C ELONEN E KANGASAHO M JOUHIKAINEN T
Citation: H. Rochant et al., RESULTS OF HEME ARGINATE TREATMENT OF MYELODYSPLASTIC SYNDROMES - A MULTICENTER PHASE-II STUDY OF THE FRENCH GROUP OF MYELODYSPLASTIC SYNDROMES, Blood, 88(10), 1996, pp. 3566-3566
HAPLO-MISMATCH TRANSPLANTATION USING CD34-BLOOD STEM-CELLS - PRELIMINARY-RESULTS OF A PILOT TRIAL( SELECTION OF DONOR PERIPHERAL)
Authors: KUENTZ M BEAUJEAN F JOUAULT H DEDHIN N RIEUX C NOROL F BERNAUDIN F CORDONNIER C ROCHANT H VERNANT JP
Citation: M. Kuentz et al., HAPLO-MISMATCH TRANSPLANTATION USING CD34-BLOOD STEM-CELLS - PRELIMINARY-RESULTS OF A PILOT TRIAL( SELECTION OF DONOR PERIPHERAL), Blood, 88(10), 1996, pp. 3843-3843
PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET IP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., PROSPECTIVE-STUDY OF AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 507-507
QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B HOANGNGOC L MALOSIEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N IFRAH N ABGRALL IP GUYOTAT D DUPRIEZ B PENY AM BRICE P PIGNON B LEPORRIER M LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP), Blood, 88(10), 1996, pp. 1807-1807
EVOLUTION OF BACTERIAL SUSCEPTIBILITY TO ANTIBIOTICS DURING A 6-YEAR PERIOD IN A HEMATOLOGY UNIT
Authors: DURANDGASSELIN B LECLERCQ R GIRARDPIPAU F DEHARVENGT MC ROCHANT H ASTIER A DUVAL J CORDONNIER C
Citation: B. Durandgasselin et al., EVOLUTION OF BACTERIAL SUSCEPTIBILITY TO ANTIBIOTICS DURING A 6-YEAR PERIOD IN A HEMATOLOGY UNIT, The Journal of hospital infection, 29(1), 1995, pp. 19-33
INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL
Authors: WATTEL P SOLARY E CAILLOT D IFRAH N BRIAN A MAHE B JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F VEIL A STOPPA AM GRATECOS N SADOUN A TILLY H BRICE P LIOURE B DESABLENS E PIGNON B ABGRALL IP LEPORRIER M DUPRIEZ B GUYOTAT D MERLAT A FENAUX P
Citation: P. Wattel et al., INTENSIVE CHEMOTHERAPY (CT) WITH OR WITHOUT QUININE FOLLOWED BY AUTOLOGOUS BMT IN MYELODYSPLASTIC SYNDROMES (MDS) AND SECONDARY LEUKEMIAS (SL) - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL, Blood, 86(10), 1995, pp. 3204-3204
IMPACT OF MAGNETIC-RESONANCE-IMAGING ON THE DIAGNOSIS OF ABDOMINAL COMPLICATIONS OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: MATHIEU D RAHMOUNI A VILLENEUVE P ANGLADE MC ROCHANT H VASILE N
Citation: D. Mathieu et al., IMPACT OF MAGNETIC-RESONANCE-IMAGING ON THE DIAGNOSIS OF ABDOMINAL COMPLICATIONS OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, Blood, 85(11), 1995, pp. 3283-3288
MANAGING THE DIFFUSION OF AN INNOVATING H EALTH-CARE TECHNIQUE - THE CASE OF POLYVALENT INTRAVENOUS IMMUNOGLOBULINS AT THE UNIVERSITY HOSPITALS OF PARIS
Authors: MINVIELLE E VIENSBITKER C ROCHANT H BAUR M BUSSEL A SOUAG A KAZATCHKINE M ETIENNE JP
Citation: E. Minvielle et al., MANAGING THE DIFFUSION OF AN INNOVATING H EALTH-CARE TECHNIQUE - THE CASE OF POLYVALENT INTRAVENOUS IMMUNOGLOBULINS AT THE UNIVERSITY HOSPITALS OF PARIS, Annales de medecine interne, 146(1), 1995, pp. 19-24
EXHAUSTIVE ANALYSIS OF THE P53 GENE CODING SEQUENCE BY DENATURING GRADIENT GEL-ELECTROPHORESIS - APPLICATION TO THE DETECTION OF POINT MUTATIONS IN ACUTE LEUKEMIAS
Authors: PIGNON JM VINATIER I FANEN P JONVEAUX P TOURNILHAC O IMBERT M ROCHANT H GOOSSENS M
Citation: Jm. Pignon et al., EXHAUSTIVE ANALYSIS OF THE P53 GENE CODING SEQUENCE BY DENATURING GRADIENT GEL-ELECTROPHORESIS - APPLICATION TO THE DETECTION OF POINT MUTATIONS IN ACUTE LEUKEMIAS, Human mutation, 3(2), 1994, pp. 126-132
A MULTICENTRIC RANDOMIZED STUDY OF ALPHA-2B INTERFERON (IFN) AND HYDROXYUREA (HU) WITH OR WITHOUT CYTOSINE-ARABINOSIDE (ARA-C) IN PREVIOUSLY UNTREATED PATIENTS WITH PH-LEUKEMIA (CML) - PRELIMINARY CYTOGENETIC RESULTS( CHRONIC MYELOCYTIC)
Authors: GUILHOT F ABGRALL JF HAROUSSEAU JL BAUTERS F BRICE P DINE G TILLY H IFRAH N CASSASUS P ROCHANT H CHRISTIAN B GUERCI A LAMAGNERE JP LEPRISE PY DUCLOS B TANZER J
Citation: F. Guilhot et al., A MULTICENTRIC RANDOMIZED STUDY OF ALPHA-2B INTERFERON (IFN) AND HYDROXYUREA (HU) WITH OR WITHOUT CYTOSINE-ARABINOSIDE (ARA-C) IN PREVIOUSLY UNTREATED PATIENTS WITH PH-LEUKEMIA (CML) - PRELIMINARY CYTOGENETIC RESULTS( CHRONIC MYELOCYTIC), Leukemia & lymphoma, 11, 1993, pp. 181-183
TRANSFUSIONS IN CLINICAL HEMATOLOGY - REC OMMENDATIONS OF THE EVALUATION COMMISSION OF THE COLLEGE FRANCAIS DES HEMATOLOGISTES FOR TRANSFUSION SUPPORT SYSTEMS IN THE TREATMENT OF ACUTE-LEUKEMIA
Authors: ANDREU G BENBUNAN M BOASSON M BUSSEL A CORDONNIER C DOSQUET P MARIE JP MICLEA JM MONCONDUIT M NOROL F RAIN JD REIFFERS J ROCHANT H VARET B WATTEL E
Citation: G. Andreu et al., TRANSFUSIONS IN CLINICAL HEMATOLOGY - REC OMMENDATIONS OF THE EVALUATION COMMISSION OF THE COLLEGE FRANCAIS DES HEMATOLOGISTES FOR TRANSFUSION SUPPORT SYSTEMS IN THE TREATMENT OF ACUTE-LEUKEMIA, Nouvelle revue francaise d'hematologie, 35(6), 1993, pp. 517-522
EXHAUSTIVE ANALYSIS OF THE P53 GENE CODING SEQUENCE BY DENATURING GRADIENT GEL-ELECTROPHORESIS (DGGE) IN ACUTE LEUKEMIAS
Authors: PIGNON JM FANEN P VINATIER I JONVEAUX P TOURNILHAC O IMBERT M ROCHANT H GOOSSENS M
Citation: Jm. Pignon et al., EXHAUSTIVE ANALYSIS OF THE P53 GENE CODING SEQUENCE BY DENATURING GRADIENT GEL-ELECTROPHORESIS (DGGE) IN ACUTE LEUKEMIAS, Blood, 82(10), 1993, pp. 10000531-10000531
MYELOFIBROSIS OF POSSIBLE AUTOIMMUNE ORIGIN MISLEADING FOR MYELODYSPLASTIC SYNDROMES (MDS)
Authors: PIGNON JM JOUAULT H IMBERT M CORDONNIER C LAATIRI M TULLIEZ M ROCHANT H
Citation: Jm. Pignon et al., MYELOFIBROSIS OF POSSIBLE AUTOIMMUNE ORIGIN MISLEADING FOR MYELODYSPLASTIC SYNDROMES (MDS), Blood, 82(10), 1993, pp. 10000555-10000555
Risultati: 1-23 |